21Shares

21Shares Hyperliquid Staking ETF submitted its annual 10-K report to the SEC on September 23, fulfilling standard regulatory requirements for SEC-registered investment funds.

21Shares has filed an amendment to its Form S-1 registration with the SEC for an Injective ETF on September 18. The update suggests the company is refining its application, though full regulatory approval remains pending.

21Shares filed benchmark licensing agreements with FTSE for three crypto ETFs (Ethereum$2,616.36 Staking, XRP$1.5166, and Solana$76.56 Staking) on August 26, along with a trust agreement amendment for the Ark 21Shares Bitcoin$83,460.63 ETF. The filings represent routine regulatory compliance updates.

21Shares Dogecoin$0.09301 ETF filed its quarterly 10-Q report with the SEC on August 11, 2026.

21Shares Solana ETF filed an 8-K with the SEC on July 27 containing a press release announcement, signaling a material update from one of crypto's leading ETF providers. Details of the announcement require further investigation.

Major cryptocurrency ETF providers including 21Shares and Ark filed routine SEC 8-K current reports on July 7 for Bitcoin$83,460.63, Ethereum$2,616.36, Solana$76.56, and other crypto asset ETFs. Defi Technologies also submitted a regulatory filing dated the same day. These appear to be standard fund management disclosures rather than enforcement actions.